Literature DB >> 15290152

Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.

Brett J Rosenblatt1, Gaurav K Shah, Sanjay Sharma, Jeff Bakal.   

Abstract

BACKGROUND: This is a retrospective study designed to investigate the effect of pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling on diabetic macular edema in eyes that do not have a taut hyaloid and have been refractory to standard laser treatment.
METHODS: Review of 26 eyes of 20 patients consecutively were treated with PPV with ILM peel for refractory diabetic macular edema. Eyes were included if they had been unresponsive to conventional treatment defined as at least two focal laser applications by a retina specialist. Paired t-testing was performed to determine if a change in both optical coherence tomography (OCT)-measured retinal thickness and logarithm of the minimum angle of resolution (logMAR) visual acuity occurred prior to and following PPV with epiretinal membrane vitrectomy. In addition, we performed multivariate regression analysis to determine if any clinical variables predicted a change in visual acuity.
RESULTS: The mean age in the sample was 65 years (range 29-81 years). The mean follow-up time was 242 days (range 35-939). Sixteen of the 26 eyes were phakic and the remaining ten were pseudophakic. There was a statistically significant improvement of mean visual acuity from a preoperative logMAR vision of 1.0 to a best postoperative vision of 0.75 (p=0.016, paired t-test). Thirteen (50%) of the 26 eyes gained at least two lines of best-corrected Snellen acuity, three (11.5%) had a decline of at least two lines, and ten (38.5%) showed stable visual acuity. Regression analysis demonstrated that baseline worse visual acuity was the only clinical variable that was associated with improvement in visual acuity (beta=0.602, p=0.016; R (2)=28.7). Fourteen eyes had preoperative and postoperative OCT. Thirteen eyes (93%) had a significant decrease in foveal thickness; with an average preoperative thickness of 575 mum compared to a postoperative average of 311 mum (t=3.65, p=0.002). No surgical complications were observed during the follow-up period.
CONCLUSIONS: Surgery for refractory diabetic edema without a taut hyaloid is associated with a significant improvement in visual acuity and diminution of retinal thickness as measured by OCT. Further investigations are warranted to define the role of surgery in the management of persistent diabetic macular edema.

Entities:  

Mesh:

Year:  2004        PMID: 15290152     DOI: 10.1007/s00417-004-0958-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid.

Authors:  T Ikeda; K Sato; T Katano; Y Hayashi
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.

Authors:  S D Pendergast; T S Hassan; G A Williams; M S Cox; R R Margherio; P J Ferrone; B R Garretson; M T Trese
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

3.  Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy.

Authors:  Pascale Massin; Graham Duguid; Ali Erginay; Belkacem Haouchine; Alain Gaudric
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

4.  Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Retina       Date:  2000       Impact factor: 4.256

5.  Pars plana vitrectomy in diabetic macular edema.

Authors:  T Micelli Ferrari; N Cardascia; G Durante; M Vetrugno; L Cardia
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

6.  Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema.

Authors:  R J Olk
Journal:  Ophthalmology       Date:  1986-07       Impact factor: 12.079

7.  Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.

Authors:  Mark L Nelson; Matthew T S Tennant; Arunan Sivalingam; Carl D Regillo; Jonathan B Belmont; Adam Martidis
Journal:  Retina       Date:  2003-10       Impact factor: 4.256

8.  Macular pucker removal with and without internal limiting membrane peeling: pilot study.

Authors:  Donald W Park; Pravin U Dugel; Jennifer Garda; Jack O Sipperley; Allen Thach; Scott R Sneed; Jennifer Blaisdell
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

9.  Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane.

Authors:  J W Harbour; W E Smiddy; H W Flynn; P E Rubsamen
Journal:  Am J Ophthalmol       Date:  1996-04       Impact factor: 5.258

10.  Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

Authors:  Jost B Jonas; Ingrid Kreissig; Antje Söfker; Robert F Degenring
Journal:  Arch Ophthalmol       Date:  2003-01
View more
  22 in total

1.  Combination of vitrectomy, IVTA, and laser photocoagulation for diabetic macular edema unresponsive to prior treatments; 3-year results.

Authors:  Yun Taek Kim; Se Woong Kang; Sang Jin Kim; Sung Min Kim; Song Ee Chung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-10       Impact factor: 3.117

2.  Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.

Authors:  Atul Kumar; Subijay Sinha; Rajvardhan Azad; Yog Raj Sharma; Rajpal Vohra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-09       Impact factor: 3.117

3.  Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.

Authors:  S P Shah; M Patel; D Thomas; S Aldington; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

4.  Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema.

Authors:  Kaoru Tamura; Toshiyuki Yokoyama; Nobuyuki Ebihara; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2012-03-23       Impact factor: 2.447

5.  Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations.

Authors:  Matthias Gutfleisch; Georg Spital; Anne Mingels; Daniel Pauleikhoff; Albrecht Lommatzsch; Arnd Heiligenhaus
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

6.  Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy.

Authors:  Yoshifumi Okamoto; Fumiki Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Jpn J Ophthalmol       Date:  2014-04-29       Impact factor: 2.447

7.  Effect of vitrectomy on macular microcirculation in patients with diffuse diabetic macular edema.

Authors:  Jung Hyun Park; Se Joon Woo; Youn Jin Ha; Hyeong Gon Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-18       Impact factor: 3.117

8.  Diabetic retinopathy - An update.

Authors:  Abdulrahman A Alghadyan
Journal:  Saudi J Ophthalmol       Date:  2011-01-31

9.  Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.

Authors:  Polly A Quiram; Victor R Leverenz; Robert M Baker; Loan Dang; Frauk J Giblin; Michael T Trese
Journal:  Retina       Date:  2007-10       Impact factor: 4.256

Review 10.  Visualizing vitreous in vitrectomy by triamcinolone.

Authors:  Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-20       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.